ALICANDRO, GIANFRANCO
ALICANDRO, GIANFRANCO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-month real-world study
2025 G. Alicandro, L. Zazzeron, V. Visciola, A. Bulfamante, A. Biffi, F. Corti, A. Gramegna, F. Blasi, V. Daccò
Andamenti di mortalità per tumore nei giovani in Italia
2025 C. Santucci, S. Mignozzi, G. Alicandro, M. Pizzato, E. Negri, P. Jha, C. La Vecchia
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometry
2025 G. Alicandro, V. Terlizzi, L. Zazzeron, D. Dolce, L. Cariani, A. Fiandaca, S. Campana, A. Terminiello, D. Innocenti, F. Blasi, V. Daccò
Cancer as a main contributor to multimorbidity in the UK Biobank: analysis of risk factors using conventional statistical modelling and machine learning
2025 L. Patel, S. Mignozzi, M. Pizzato, G. Corso, C. La Vecchia, G. Alicandro
The toll of excess mortality in Europe in 2020-2023
2025 G.A. Gerli, G. Alicandro, M. Pizzato, C. La Vecchia
Indices of helthy and unhealthy plant-based diets and the risk of selected digestive cancers
2025 F. Turati, S. Mignozzi, G. Esposito, F. Bravi, A. D'Angelo, G. Alicandro, W. Garavello, L.S.A. Augustin, S. Vitale, A. Giacosa, E. Bidoli, J. Polesel, E. Negri, M. Ferraroni, C. La Vecchia
Cancers attributable to diet in Italy
2025 F. Turati, G. Alicandro, G. Collatuzzo, C. Pelucchi, M. Malvezzi, F. Parazzini, E. Negri, P. Boffetta, C. La Vecchia, M. Di Maso
Trends in cancer mortality under age 50 in 15 upper-Middle and high-income countries
2025 C. Santucci, S. Mignozzi, G. Alicandro, M. Pizzato, M. Malvezzi, E. Negri, P. Jha, C. La Vecchia
Overall and cause-specific excess deaths during the COVID-19 pandemic
2025 C. Santucci, G. Alicandro, M. Pizzato, C.V.B. La Vecchia
All-cause and All-Specific Excess Deaths during the COVID-19 Pandemic
2025 M. Pizzato, C. Santucci, C. La Vecchia, G. Alicandro
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
2025 C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò
Excess mortality at ages 20-64 from 2020 to 2024: a comparative analysis of 16 European countries
2025 G. Alicandro, A.G. Gerli, C. La Vecchia
Relationship between COVID-19 cases and monthly mortality from all causes, cancer, cardiovascular diseases and diabetes in 16 countries, 2020-21
2025 M. Pizzato, C. Santucci, N. Islam, C. La Vecchia, G. Alicandro
Cancer mortality in Europe in 2020, and an overview of trends since 1990
2025 C. Santucci, P. Bertuccio, S. Mignozzi, M. Pizzato, G. Corso, A. Odone, E. Negri, C. La Vecchia, G. Alicandro
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021
2025 M. Naghavi, G. Zamagni, C. Abbafati, B. Armocida, A. Agodi, G. Alicandro, F. Barbic, M. Barchitta, M. Bauckneht, M. Beghi, R. Bugiardini, A. Capodici, C. Carletti, G. Carreras, A. Carugno, M.S. Cattaruzza, E. Cenko, S. Cerrai, I. Cioffi, S. Conti, P.A. Cortesi, G. Damiani, N. Davis Weaver, C. Del Bo', N. Fabin, L. Falzone, F.O. Fasina, P. Ferrara, O.E. Ferraro, M. Fonzo, C. Fornari, D. Fortuna, M. Foschi, F. Gemmi, S.D. Glenn, D. Golinelli, G. Gorini, G. Guarducci, S. Guicciardi, M. Jakovljevic, C. La Vecchia, F. Lanfranchi, P. Lauriola, C. Ledda, M. Leonardi, G. Logroscino, A. Lugo, L.G. Mantovani, D. Martini, G. Minelli, A. Mirijello, A.H. Mokdad, S. Molinaro, L. Muccioli, L. Naldi, L. Nieddu, R. Palladino, P. Pani, M. Pasovic, R. Passera, P. Pedersini, U. Pensato, N. Perico, D. Pierannunzio, A. Raggi, G. Remuzzi, M. Romozzi, M. Russo, S. Sacco, D. Trico, M. Valenti, F.S. Violante, J. Månsson, M. Naghavi, L. Ronfani, L. Monasta
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting
2024 V. Daccò, C. Rosazza, A. Mariani, C. Rizza, N. Ingianni, E. Nazzari, V. Terlizzi, F.A. Blasi, G. Alicandro
COVID-19 cases and monthly all-cause, cancer, CVD and diabetes mortality in 16 countries, 2020-2021
2024 C. Santucci, M. Pizzato, C.V.B. LA VECCHIA, G. Alicandro
Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantation
2024 V. Grancini, I. Cogliati, G. Alicandro, A. Gaglio, S. Gatti, M.F. Donato, E. Orsi, V. Resi
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
2024 G. Alicandro, A. Gramegna, F. Bellino, S.C. Sciarrabba, C. Lanfranchi, M. Contarini, M. Retucci, V. Daccò, F. Blasi
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
2024 A. Gramegna, G. Alicandro, C. Premuda, F. Lucca, L. Pinali, M. Retucci, V. Vespro, M.C. Andrisani, G. Carraffiello, F. Amati, S. Volpi, S. Aliberti, M. Cipolli, F. Blasi